Ken Griffin Precigen, Inc. Transaction History

Citadel Advisors LLC

$505 Billion
Q3 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Precigen, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 85,300 shares of PGEN stock, worth $71,652. This represents 0.0% of its overall portfolio holdings.

Number of Shares

85,300

Previous 78,200 9.08%

Holding current value

$71,652

Previous $123,000 34.15%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$0.91 - $1.88 $33,448 - $69,103	-36,757 Reduced 8.76%	382,999 $363,000
Q2 2024 Aug 14, 2024	BUY	$1.27 - $1.75 $130,175 - $179,375	102,500 Added 32.31%	419,756 $663,000
Q1 2024 May 15, 2024	SELL	$1.21 - $1.75 $259,259 - $374,962	-214,264 Reduced 40.31%	317,256 $460,000
Q4 2023 Feb 14, 2024	BUY	$0.89 - $1.41 $208,899 - $330,952	234,718 Added 79.08%	531,520 $712,000
Q3 2023 Nov 14, 2023	BUY	$1.08 - $1.85 $293,675 - $503,055	271,922 Added 1092.93%	296,802 $421,000
Q2 2023 Aug 14, 2023	SELL	$0.96 - $1.4 $525,252 - $765,993	-547,138 Reduced 95.65%	24,880 $28,000
Q1 2023 May 15, 2023	BUY	$0.88 - $2.19 $62,404 - $155,301	70,914 Added 14.15%	572,018 $606,000
Q4 2022 Feb 14, 2023	SELL	$1.27 - $2.26 $19,240 - $34,239	-15,150 Reduced 2.93%	501,104 $761,000
Q3 2022 Nov 14, 2022	SELL	$1.41 - $2.79 $419,348 - $829,773	-297,410 Reduced 36.55%	516,254 $1.1 Million
Q2 2022 Aug 15, 2022	BUY	$1.15 - $2.53 $174,031 - $382,869	151,332 Added 22.85%	813,664 $1.09 Million
Q1 2022 May 16, 2022	BUY	$1.91 - $3.98 $1.09 Million - $2.26 Million	568,738 Added 607.67%	662,332 $1.4 Million
Q4 2021 Feb 14, 2022	SELL	$3.53 - $5.5 $1.11 Million - $1.73 Million	-314,598 Reduced 77.07%	93,594 $347,000
Q3 2021 Nov 15, 2021	SELL	$4.99 - $6.55 $4.18 Million - $5.49 Million	-838,180 Reduced 67.25%	408,192 $2.04 Million
Q2 2021 Aug 16, 2021	BUY	$6.24 - $8.22 $5.09 Million - $6.7 Million	815,582 Added 189.32%	1,246,372 $8.13 Million
Q1 2021 May 17, 2021	BUY	$6.74 - $10.95 $2.78 Million - $4.51 Million	412,011 Added 2194.0%	430,790 $2.97 Million
Q4 2020 Feb 16, 2021	SELL	$3.75 - $10.56 $1.09 Million - $3.07 Million	-290,423 Reduced 93.93%	18,779 $192,000
Q3 2020 Nov 16, 2020	BUY	$3.5 - $6.2 $259,416 - $459,537	74,119 Added 31.53%	309,202 $1.08 Million
Q2 2020 Aug 14, 2020	BUY	$2.16 - $5.46 $247,006 - $624,378	114,355 Added 94.72%	235,083 $1.17 Million
Q1 2020 May 15, 2020	BUY	$1.46 - $7.19 $176,262 - $868,034	120,728 New	120,728 $411,000

Others Institutions Holding PGEN

# of Institutions

143

Shares Held

159M

Call Options Held

232K

Put Options Held

69K

View Full List

About PRECIGEN, INC.

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $175M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

More about PGEN

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account